Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Johnson and Johnson
Moodys
Express Scripts
Medtronic

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Patent: 5,503,841

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 5,503,841
Title: Human IL-2 as a vaccine adjuvant
Abstract:Methods for enhancing the immune response to vaccination in animals, including humans, comprise administering interleukin-2 (IL-2) as part of the vaccination regimen, preferably for 5 to 14 days post-vaccination. In addition, compositions for enhancing the immune response of an animal to a vaccine employ IL-2 as an active ingredient, preferably human IL-2.
Inventor(s): Doyle; Michael V. (Oakland, CA), Newell; Arthur D. (Orinda, CA), Nunberg; Jack H. (Oakland, CA), White; Thomas J. (Oakland, CA)
Assignee: Cetus Oncology Corporation (Emeryville, CA)
Application Number:07/314,975
Patent Claims:see list of patent claims

Details for Patent 5,503,841

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bavarian Nordic A/s RABAVERT rabies vaccine For Injection 103334 1997-10-20 ⤷  Free Forever Trial 2005-09-20
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
McKesson
Merck
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.